Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 8, August, p. 1013–1020

doi: 10.17219/acem/94145

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Dietary curcumin and capsaicin: Relationship with hepatic oxidative stress and apoptosis in rats fed a high fat diet

Sevda Tanrıkulu-Küçük1,A,D,F, Canan Başaran-Küçükgergin2,B,C, İbrahim Söğüt3,B, Matem Tunçdemir4,B, Semra Doğru-Abbasoğlu2,A,C, Muhammed Seyithanoğlu5,A,B, Hikmet Koçak1,C,D,E, Yıldız Öner-İyidoğan2,A,C,D

1 Department of Biochemistry, Faculty of Medicine, Istanbul Bilim University, Turkey

2 Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Turkey

3 Vocational School of Health Services, Istanbul Bilim University, Turkey

4 Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Turkey

5 Department of Biochemistry, Faculty of Medicine, Kahramanmaraş Sütçü Imam University, Turkey


Background. Apoptosis plays a major role in fatty liver disease. High-fat diets are related to the onset of fatty liver disease and hepatic oxidant–antioxidant imbalance. Curcumin and capsaicin are somewhat beneficial in reducing hepatic triglycerides; this is most likely because they are known to downregulate reactive oxygen species (ROS) and apoptosis.
Objectives. The aim of this study was to investigate the effects of curcumin and capsaicin on apoptosis through the oxidative effect in an animal model of fatty liver disease.
Material and Methods. Male Sprague Dawley rats were fed a normal control diet, a high-fat diet (HFD; 60% of total calories from fat), a HFD+curcumin (1.5 g curcumin/kg HFD), a HFD+capsaicin (0.15 g capsaicin/kg HFD), or a HFD+curcumin+capsaicin (1.5 g curcumin and 0.15 g capsaicin/kg HFD). Liver lysate levels of BAX, Bcl-2 and caspase-3 were determined via immunoblotting. Caspase-3 activity was measured with a colorimetric caspase-3 measurement kit. Total antioxidant status (TAS) and total oxidant status (TOS) were assayed using commercial kits. The generation of hepatic ROS was measured with fluorimetry. Fragmentation of DNA was detected using the TUNEL method.
Results. High-fat diet caused increased expression of BAX and caspase-3, as well as increased TOS and caspase-3 activity, but decreased expression of Bcl-2. HFD+curcumin+capsaicin caused decreased BAX, caspase-3, TOS, and ROS levels as compared to HFD, but increased TAS and Bcl-2. A HFD +curcumin+capsaicin also decreased the number of TUNEL-positive cells.
Conclusion. These results suggest that supplementation with curcumin and capsaicin balances the hepatic oxidant-antioxidant status and may have a protective role in the apoptotic process in an HFD-induced fatty liver model.

Key words

apoptosis, curcumin, high-fat diet, fatty liver, capsaicin

References (40)

  1. Cao L, Quan XB, Zeng WJ, Yang XO, Wang MJ. Mechanism of hepatocyte apoptosis. J Cell Death. 2016;9:19–29.
  2. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2002;282(2):193–199.
  3. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity diabetes and inflammation. Circulation. 2005;111(11):1448–1454.
  4. Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. Biofactors. 2013;39(1):88–100.
  5. Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009;30(1–2):29–41.
  6. Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Oxidative stress cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(39):14205–14218.
  7. Öner-İyidoğan Y, Tanrıkulu-Küçük S, Seyithanoğlu M, et al. Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: Is there a triangular relationship? Can J Physiol Pharmacol. 2014;92(10):805–812.
  8. Seyithanoğlu M, Öner-İyidoğan Y, Doğru-Abbasoğlu S, et al. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Arch Physiol Biochem. 2016;122(2):94–102.
  9. Sharma SK, Vij AS, Sharma S. Mechanisms and clinical uses of capsaicin. Eur J Pharm. 2013;720(1–3):55–62.
  10. Li Q, Li L, Wang F, et al. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation. Pflugers Arch – Eur J Physiol. 2013;465(9):1303–1316.
  11. Manjunatha H, Srinivasan K. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can J Physiol Pharmacol. 2007;85(6):588–596.
  12. Toydemir T, Kanter M, Erboga M, Oguz S, Erenoglu C. Antioxidative, antiapoptotic, and proliferative effect of curcumin on liver regeneration after partial hepatectomy in rats. Toxicol Ind Health. 2015;31(2):162–172.
  13. Wang L, Yisong Iv, Huixiang Y, Yin L, Shang J. Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction. Int J Clin Exp Pathol. 2015;8(9):11503–11509.
  14. Becatti M, Prignano F, Fiorillo C, et al. The involvement of Smac/DIABLO p53 NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010;13(9):1309–1321.
  15. Joe B, Lokesh BR. Role of capsaicin curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta. 1994;1224(2):255–263.
  16. Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 2009;139(5):919–925.
  17. Kang JH, Tsuyoshi G, Le Ngoc H, et al. Dietary capsaicin attenuates metabolic dysregulation in genetically obese diabetic mice. J Med Food. 2011;14(3):310–315.
  18. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226(1):497–509.
  19. Aycicek A, Iscan A, Erel O, Akcali M, Selek S. Total antioxidant/oxidant status in meningism and meningitis. Pediatr Neurol. 2006;35(6):382–386.
  20. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999;27(5–6):612–616.
  21. Kartkaya K, Kanbak K, Oglakci A, Burukoglu D, Ozer MC. Protective effect of calpain inhibitor N-acetyl-L-leucyl-L-leucyl-L-norleucinal on acute alcohol consumption related cardiomyopathy. Mol Biol Rep. 2014;41(10):6743–6753.
  22. Tunçdemir M, Ertürküner SP, Özçelik D. Investigation of lipid peroxidation and antiapoptotic effects of zinc against liver damage in diabetic rats. Hum Exp Toxicol. 2017;36(8):813–822.
  23. Peng Y, Rideout DA, Rakita SS, Gower WR Jr, You M, Murr MM. Does LKB1 mediate activation of hepatic AMP-protein kinase [AMPK] and sirtuin1 [SIRT1] after Roux-en-Y gastric bypass in obese rats? J Gastrointest Surg. 2010;14(2):221–228.
  24. Liu ES, Ye YN, Shin VY, et al. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis. 2003;24(8):1407–1413.
  25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685.
  26. Soeda J, Miyagawa S, Sano K, Masumoto J, Taniguchi S, Kawasaki S. Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver. Am J Physiol Gastrointest Liver Physiol. 2001;281(4):1115–1123.
  27. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343–1351.
  28. Chiang DJ, McCullough AJ. The impact of obesity and metabolic syndrome on alcoholic liver disease. Clin Liver Dis. 2014;18(1):157–163.
  29. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407(6805):770–776.
  30. Ravindranath V, Chandrasekhara N. Metabolism of curcumin studies with [3H] curcumin. Toxicology. 1981;22(4):337–344.
  31. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353–356.
  32. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharmaceutics. 2009;4(6):807–818.
  33. Rollyson WD, Stover CA, Brown KC, et al. Bioavailability of capsaicin and its implications for drug delivery. J Control Release. 2014;196:96–105.
  34. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
  35. Yu FX, Teng YY, Zhu QD, Zhang QY, Tang YH. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis. Biochem Cell Biol. 2014;92(5):406–412.
  36. Galaly SR, Ahmed OM, Mahmoud AM. Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress inflammation and apoptosis. J Physiol Pharmacol. 2014;65(6):823–832.
  37. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456–1462.
  38. Truong-Tran AQ, Grosser D, Ruffin RE. Apoptosis in the normal and inflamed airway epithelium: Role of zinc in epithelial protection and procaspase-3 regulation. Biochem Pharmacol. 2003;66(8):1459–1468.
  39. Kressel M, Groscurth P. Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA. Cell Tissue Res. 1994;278(3):549–556.
  40. Dikalov SI, Li W, Mehranpour P, Wang SS, Zafari AM. Production of extracellular superoxide by human lymphoblast cell lines: Comparison of electron spin resonance techniques and cytochrome C reduction assay. Biochem Pharmacol. 2007;73(7):972–980.